Antoine Giraud

Antoine Giraud

Auto-generated profile, based on publicly available information

Antoine Giraud

Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2001 in Science
Verified
Journal Article
Closed access
PDF file
AGAntoine Giraud
Antoine Giraud
IMIvan Matic
Ivan Matic
OTOlivier Tenaillon
Olivier Tenaillon
ACAntonio Clara
Antonio Clara
MRMiroslav Radman
Miroslav Radman
FTFrançois Taddei
François Taddei
We have shown that bacterial mutation rates change during the experimental colonization of the mouse gut. A high mutation rate was initially beneficial because it allowed faster adaptation, but this benefit disappeared once adaptation was achieved. Mutator bacteria accumulated mutations that, although neutral in the mouse gut, are often deleterious in secondary environments. Consistently, the competitiveness of mutator bacteria is reduced during transmission to and re-colonization of similar hosts. The short-term advantages and long-term disadvantages of mutator bacteria could account for their frequency in nature.

22 October 2015 in Blood
Verified
Journal Article
Open access
PDF file
SMSara Massena
Sara Massena
GCGustaf Christoffersson
Gustaf Christoffersson
EVEvelina Vågesjö
Evelina Vågesjö
CSCédric Seignez
Cédric Seignez
KGKarin Gustafsson
Karin Gustafsson
MPMia Phillipson
Mia Phillipson
Key Points: Circulating CD49d+VEGFR1highCXCR4high neutrophils that stimulate angiogenesis at sites of hypoxia were identified in mice and humans. This subset was recruited to tissue by VEGF-A in a VEGFR1- and VEGFR2-dependent manner, and anti-CD49d therapy inhibited their extravasation.

1 October 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JBJean-Christophe Bambou
Jean-Christophe Bambou
AGAntoine Giraud
Antoine Giraud
SSandrine Menard
Sandrine Menard
BBBernadette Begue
Bernadette Begue
SRSabine Rakotobe
Sabine Rakotobe
VGValérie Gaboriau-Routhiau
Valérie Gaboriau-Routhiau
The capacity of non-pathogenic enteric bacteria to induce a pro-inflammatory response is under debate in terms of its effect on the symbiosis between the mammalian host and its commensal gut microflora. Activation of NF-kappaB and induction of interleukin-8 (IL-8) and CCL-20 by the commensal Escherichia coli strain MG1655 were first studied in vitro in the human intestinal epithelial cell (IECs) lines HT29-19A and Caco-2, transfected or not with plasmids encoding dominant negative Toll-like receptor (TLR) 5 and myeloid differentiation factor-88 (MyD88) adaptor protein. The response of enterocytes in situ was then assessed using murine ileal biopsies mounted in Ussing chambers. Commensal E. coli induced NF-kappaB DNA binding, NF-kappaB transcriptional activity, CCL-20 expression, and IL-8 secretion in the human IEC lines. E. coli MG1655 flagellin was necessary and sufficient to trigger this pro-inflammatory pathway via its interaction with TLR5 and the subsequent recruitment of the adaptor protein MyD88. Following epithelial cell polarization, signaling could be induced by live E. coli and flagellin on the apical side of HT29-19A. The in vivo relevance of our findings was confirmed, because immunohistochemical staining of murine ileum demonstrated expression of TLR5 in the apical part of enterocytes in situ. Furthermore, flagellin added on the mucosal side of murine ileal biopsies mounted in Ussing chambers induced a basolateral production of KC, a functional murine homolog of human IL-8. These findings provide strong evidence that flagellin released by flagellated commensal bacteria in the intestinal lumen can induce a pro-inflammatory response in enterocytes in vivo.

15 January 2002 in Journal of Bacteriology
Verified
Journal Article
Open access
EDErick Denamur
Erick Denamur
SBStéphane Bonacorsi
Stéphane Bonacorsi
AGAntoine Giraud
Antoine Giraud
PDPatrick Duriez
Patrick Duriez
FHFarida Hilali
Farida Hilali
IMIvan Matic
Ivan Matic
By using a panel of 603 commensal and pathogenic Escherichia coli and Shigella isolates, we showed that mutation rates of strains vary considerably among different ecotypes. Uropathogenic strains had the highest frequency of mutators, while strains from patients with bacteremia had the lowest mutation rates. No correlation between the mutation rates and antibiotic resistance was observed among the studied strains.

1 October 2001 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
AGA Giraud
A Giraud

11 January 2008 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
AGAntoine Giraud
Antoine Giraud
SASafia Arous
Safia Arous
MPMarianne De Paepe
Marianne De Paepe
VGValérie Gaboriau-Routhiau
Valérie Gaboriau-Routhiau
JBJean-Christophe Bambou
Jean-Christophe Bambou
NCNadine Cerf-Bensussan
Nadine Cerf-Bensussan
While pleiotropic adaptive mutations are thought to be central for evolution, little is known on the downstream molecular effects allowing adaptation to complex ecologically relevant environments. Here we show that Escherichia coli MG1655 adapts rapidly to the intestine of germ-free mice by single point mutations in EnvZ/OmpR two-component signal transduction system, which controls more than 100 genes. The selective advantage conferred by the mutations that modulate EnvZ/OmpR activities was the result of their independent and additive effects on flagellin expression and permeability. These results obtained in vivo thus suggest that global regulators may have evolved to coordinate activities that need to be fine-tuned simultaneously during adaptation to complex environments and that mutations in such regulators permit adjustment of the boundaries of physiological adaptation when switching between two very distinct environments. The mammalian intestine is a privileged physiological site to study how coevolution between hosts and the trillions of bacteria present in the microbiota has shaped the genome of each partner and promoted the development of mutualistic interactions. Herein we have used germ-free mice, a simplified albeit ecologically relevant system, to analyse intestinal adaptation of a model bacterial strain, Escherichia coli MG1655. Our results show that single point mutations in the ompB master regulator confer a striking selective adaptive advantage. OmpB comprises EnvZ, a transmembrane sensor with a dual kinase/phosphatase activity, and OmpR, a transcription factor controlling more than 100 target genes. In response to environmental changes, EnvZ modulates the phosphorylation and thereby the transcriptional activity of OmpR. We further show that the selective advantage conferred by OmpB mutations is related to their additive and independent effects on genes regulating permeability and flagellin expression, two major set of genes controlled by OmpR. These results suggest that global regulators may have evolved to coordinate physiological activities necessary for adaptation to complex environments and that mutations offer a complementary genetic mechanism to adjust the scale of the physiological regulation controlled by these regulators in distinct environments.